These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10559066)

  • 61. Treatment and prophylaxis of cytomegalovirus disease.
    Levinson ML; Jacobson PA
    Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Preemptive therapy for cytomegalovirus infections and the development of resistance to ganciclovir.
    Kroes AC; Kalpoe JS
    J Infect Dis; 2002 Sep; 186(5):724-5; author reply 725-6. PubMed ID: 12195366
    [No Abstract]   [Full Text] [Related]  

  • 63. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial.
    Palmer SM; Limaye AP; Banks M; Gallup D; Chapman J; Lawrence EC; Dunitz J; Milstone A; Reynolds J; Yung GL; Chan KM; Aris R; Garrity E; Valentine V; McCall J; Chow SC; Davis RD; Avery R
    Ann Intern Med; 2010 Jun; 152(12):761-9. PubMed ID: 20547904
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cytomegalovirus prophylaxis with ganciclovir in kidney transplant recipients receiving induction antilymphocyte antibodies.
    Said T; Nampoory MR; Johny KV; Pacsa AS; Mini Abraham P; Nair MP; Abdel-Haleem M; Samhan M; Al-Mousawi M
    Transplant Proc; 2004; 36(6):1847-9. PubMed ID: 15350495
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ganciclovir susceptibilities and analysis of UL97 region in cytomegalovirus (CMV) isolates from bone marrow recipients with CMV disease after antiviral prophylaxis.
    Erice A; Borrell N; Li W; Miller WJ; Balfour HH
    J Infect Dis; 1998 Aug; 178(2):531-4. PubMed ID: 9697737
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preemptive versus sequential prophylactic-preemptive treatment regimens for cytomegalovirus in renal transplantation: comparison of treatment failure and antiviral resistance.
    van der Beek MT; Berger SP; Vossen AC; van der Blij-de Brouwer CS; Press RR; de Fijter JW; Claas EC; Kroes AC
    Transplantation; 2010 Feb; 89(3):320-6. PubMed ID: 20145523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of valganciclovir pharmacokinetics in lung transplant recipients.
    Kiser TH; Fish DN; Zamora MR
    J Heart Lung Transplant; 2012 Feb; 31(2):159-66. PubMed ID: 22305377
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An international survey of cytomegalovirus management practices in lung transplantation.
    Zuk DM; Humar A; Weinkauf JG; Lien DC; Nador RG; Kumar D
    Transplantation; 2010 Sep; 90(6):672-6. PubMed ID: 20581765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of intravenous ganciclovir and cytomegalovirus hyperimmune globulin pre-emptive treatment in cytomegalovirus-positive heart transplant recipients.
    Vrtovec B; Thomas CD; Radovancevic R; Frazier OH; Radovancevic B
    J Heart Lung Transplant; 2004 Apr; 23(4):461-5. PubMed ID: 15063406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased incidence of cytomegalovirus infection in high-risk liver transplant recipients receiving valganciclovir prophylaxis versus ganciclovir prophylaxis.
    Shiley KT; Gasink LB; Barton TD; Pfeiffenberger P; Olthoff KM; Blumberg EA
    Liver Transpl; 2009 Aug; 15(8):963-7. PubMed ID: 19642123
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants.
    Weng FL; Patel AM; Wanchoo R; Brahmbhatt Y; Ribeiro K; Uknis ME; Mulgaonkar S; Mathis AS
    Transplantation; 2007 Feb; 83(3):290-6. PubMed ID: 17297403
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytomegalovirus prophylaxis in solid organ transplant recipients.
    Patel R; Snydman DR; Rubin RH; Ho M; Pescovitz M; Martin M; Paya CV
    Transplantation; 1996 May; 61(9):1279-89. PubMed ID: 8629285
    [No Abstract]   [Full Text] [Related]  

  • 73. Prevention of cytomegalovirus disease in transplant recipients.
    Snydman DR; Falagas ME
    Lancet; 1996 Jan; 347(8996):268-9. PubMed ID: 8551918
    [No Abstract]   [Full Text] [Related]  

  • 74. Ganciclovir pre-emptive therapy for cytomegalovirus antigenemia in a pemphigus vulgaris patient.
    Shibata A; Yoshikawa T; Makita S; Takami N; Matsuzaki T; Sugiyama Y; Akiyama M
    J Dermatol; 2019 Nov; 46(11):e423-e424. PubMed ID: 31355464
    [No Abstract]   [Full Text] [Related]  

  • 75. Prophylaxis of cytomegalovirus primary infection with short-term ganciclovir therapy.
    Lauzurica R; Bayés B; Frías C; Hernández A; Jimenez A; Fontseré N; Romero R
    Transplant Proc; 2003 Aug; 35(5):1751-2. PubMed ID: 12962781
    [No Abstract]   [Full Text] [Related]  

  • 76. Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients.
    Danziger-Isakov LA; Storch GA
    Pediatr Infect Dis J; 2002 May; 21(5):432-4. PubMed ID: 12150182
    [No Abstract]   [Full Text] [Related]  

  • 77. Psychotic symptoms and confusion associated with intravenous ganciclovir in a heart transplant recipient.
    Southworth MR; Dunlap SH
    Pharmacotherapy; 2000 Apr; 20(4):479-83. PubMed ID: 10772379
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preemptive therapy for cytomegalovirus with oral ganciclovir after liver transplantation.
    Singh N
    Transplantation; 2002 Jun; 73(12):1977; author reply 1977-8. PubMed ID: 12131704
    [No Abstract]   [Full Text] [Related]  

  • 79. Cytomegalovirus prevention strategies: the case for prophylaxis.
    Snydman DR
    Am J Transplant; 2009 May; 9(5):1254. PubMed ID: 19422353
    [No Abstract]   [Full Text] [Related]  

  • 80. Effectiveness of aggressive prophylatic and preemptive therapies targeted against cytomegaloviral and Epstein-Barr viral disease after human intestinal transplantation.
    Farmer DG; McDiarmid SV; Winston D; Yersiz H; Cortina G; Dry S; Maxfield AJ; Vandenbogaart B; Correa M; Kroeber A; Geevarghese S; Busuttil RW
    Transplant Proc; 2002 May; 34(3):948-9. PubMed ID: 12034254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.